S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
NASDAQ:CGC

Canopy Growth Stock Forecast, Price & News

$14.71
+0.80 (+5.75 %)
(As of 09/27/2021 04:00 PM ET)
Add
Compare
Today's Range
$13.81
$14.79
50-Day Range
$13.52
$20.44
52-Week Range
$13.35
$56.50
Volume4.35 million shs
Average Volume4.57 million shs
Market Capitalization$5.79 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.05
30 days | 90 days | 365 days | Advanced Chart
Receive CGC News and Ratings via Email

Sign-up to receive the latest news and ratings for Canopy Growth and its competitors with MarketBeat's FREE daily newsletter.


Canopy Growth logo

About Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CGC
Employees
3,259
Year Founded
N/A

Sales & Book Value

Annual Sales
$414.03 million
Book Value
$6.90 per share

Profitability

Net Income
$-1,322,470,000.00
Net Margins
-200.71%

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$5.79 billion
Next Earnings Date
11/8/2021 (Estimated)
Optionable
Optionable

MarketRank

Overall MarketRank

1.32 out of 5 stars

Medical Sector

1113th out of 1,353 stocks

Medicinals & Botanicals Industry

12th out of 18 stocks

Analyst Opinion: 4.1Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Canopy Growth (NASDAQ:CGC) Frequently Asked Questions

Is Canopy Growth a buy right now?

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 1 sell rating, 10 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Canopy Growth stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CGC, but not buy additional shares or sell existing shares.
View analyst ratings for Canopy Growth
or view top-rated stocks.

What stocks does MarketBeat like better than Canopy Growth?

Wall Street analysts have given Canopy Growth a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Canopy Growth wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Canopy Growth's next earnings date?

Canopy Growth is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021.
View our earnings forecast for Canopy Growth
.

How were Canopy Growth's earnings last quarter?

Canopy Growth Co. (NASDAQ:CGC) issued its quarterly earnings results on Thursday, August, 5th. The company reported $0.84 earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.18) by $1.02. The business had revenue of $136.21 million for the quarter, compared to analysts' expectations of $151.29 million. Canopy Growth had a negative net margin of 200.71% and a negative trailing twelve-month return on equity of 17.31%. The firm's revenue was up 23.4% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.30) EPS.
View Canopy Growth's earnings history
.

How has Canopy Growth's stock price been impacted by Coronavirus?

Canopy Growth's stock was trading at $13.35 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CGC stock has increased by 10.2% and is now trading at $14.71.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for CGC?

14 brokerages have issued 1 year price targets for Canopy Growth's stock. Their forecasts range from $15.00 to $55.00. On average, they anticipate Canopy Growth's share price to reach $28.23 in the next year. This suggests a possible upside of 91.9% from the stock's current price.
View analysts' price targets for Canopy Growth
or view top-rated stocks among Wall Street analysts.

Who are Canopy Growth's key executives?

Canopy Growth's management team includes the following people:
  • David Eric Klein, Chief Executive Officer & Non-Independent Director
  • Rade Kovacevic, President & Chief Product Officer
  • Andrew MacCorquodale, Chief Operations Officer
  • Mike Lee, Chief Financial Officer & Executive Vice President
  • Ru Wadasinghe, Chief Information Officer

What is Canopy Growth's stock symbol?

Canopy Growth trades on the NASDAQ under the ticker symbol "CGC."

Who are Canopy Growth's major shareholders?

Canopy Growth's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (1.80%), Susquehanna International Group LLP (0.00%), Contrarius Investment Management Ltd (0.54%), Morgan Stanley (0.54%), Morgan Stanley (0.53%) and Bank of Nova Scotia (0.49%). Company insiders that own Canopy Growth stock include Phillip Stephen Shaer, Rade Nikola Kovacevic and Tomas Iv Shipley.
View institutional ownership trends for Canopy Growth
.

Which major investors are selling Canopy Growth stock?

CGC stock was sold by a variety of institutional investors in the last quarter, including Twin Tree Management LP, Susquehanna International Group LLP, Connor Clark & Lunn Investment Management Ltd., Citadel Advisors LLC, Public Sector Pension Investment Board, Sumitomo Mitsui Trust Holdings Inc., Alberta Investment Management Corp, and Parallax Volatility Advisers L.P.. Company insiders that have sold Canopy Growth company stock in the last year include Phillip Stephen Shaer, and Rade Nikola Kovacevic.
View insider buying and selling activity for Canopy Growth
or view top insider-selling stocks.

Which major investors are buying Canopy Growth stock?

CGC stock was bought by a variety of institutional investors in the last quarter, including Contrarius Investment Management Ltd, Renaissance Technologies LLC, Vanguard Group Inc., Goldman Sachs Group Inc., Deutsche Bank AG, AMS Capital Ltda, Bank of New York Mellon Corp, and Royal Bank of Canada.
View insider buying and selling activity for Canopy Growth
or or view top insider-buying stocks.

How do I buy shares of Canopy Growth?

Shares of CGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Canopy Growth's stock price today?

One share of CGC stock can currently be purchased for approximately $14.71.

How much money does Canopy Growth make?

Canopy Growth has a market capitalization of $5.79 billion and generates $414.03 million in revenue each year. The company earns $-1,322,470,000.00 in net income (profit) each year or ($2.16) on an earnings per share basis.

How many employees does Canopy Growth have?

Canopy Growth employs 3,259 workers across the globe.

What is Canopy Growth's official website?

The official website for Canopy Growth is www.canopygrowth.com.

Where are Canopy Growth's headquarters?

Canopy Growth is headquartered at 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8.

How can I contact Canopy Growth?

Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8. The company can be reached via phone at (855) 558-9333 or via email at [email protected].


This page was last updated on 9/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.